Advicenne S.A. (EPA:ALDVI)
1.664
+0.024 (1.46%)
Aug 3, 2026, 12:45 PM CET
Advicenne Market Cap
Advicenne has a market cap or net worth of €23.86 million as of August 3, 2026. Its market cap has increased by 47.46% in one year.
Market Cap
23.86M
Enterprise Value
41.51M
Revenue
6.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.66
ChartMarket Cap Chart
Since December 6, 2017, Advicenne's market cap has decreased from 112.04M to 23.86M, a decrease of -78.70%. That is a compound annual growth rate of -16.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 23.86M | -2.66% |
| Dec 31, 2025 | 24.51M | 1.30% |
| Dec 31, 2024 | 24.20M | -25.97% |
| Dec 29, 2023 | 32.68M | -28.00% |
| Dec 30, 2022 | 45.40M | -51.76% |
| Dec 31, 2021 | 94.11M | 11.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIONYX Pharma | 65.50M |
| THX Pharma Société Anonyme | 59.33M |
| MaaT Pharma | 52.39M |
| Fermentalg | 44.28M |
| Nicox | 34.06M |
| genOway Société anonyme | 22.50M |
| GenSight Biologics | 19.13M |
| Aelis Farma | 13.92M |